ClinicalTrials.Veeva

Menu

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

HanAll Biopharma logo

HanAll Biopharma

Status and phase

Completed
Phase 1

Conditions

Hypertension

Treatments

Drug: Amlodipine10mg
Drug: Candesartan32mg

Study type

Interventional

Funder types

Industry

Identifiers

NCT01806311
HAMCAO12I_1

Details and patient eligibility

About

Clinical trial to evalate the pharmacokinetic interactions and safety between single dose of amlodipine10mg and candesartan32mg and combiation dose amlodipine10mg with candesartan32mg in healthy male volunteers.

Enrollment

36 patients

Sex

Male

Ages

20 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Healthy male, Age 20 to 45
  2. Subject must be willing and able to provide written informed consent to the study.

Exclusion criteria

  1. History of any significant sickness, liver system, gall bladder system, kidney, nerve system, respiratory system, blood tumor, endocrine system, urinary system, mental disease, muscloskeletal system, immunity system, the ear, nose and throat system and cardiovascular system.
  2. History of any significant gastrointestinal system and surgery of gastrointestinal.
  3. History of any significant hypersensitivity to amlodipine, candesartan, aspirin, antibiotic.
  4. Over 10 tobaccos a day.
  5. Other condition which in the opinion of the investigator preclude endrollment into the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

36 participants in 2 patient groups

PartA: Candesartan, Candesartan + Amolodipine
Active Comparator group
Description:
Candesartan : multiple dose 32mg administered orally Amlodipine : multiple dose 10mg administered orally
Treatment:
Drug: Candesartan32mg
Drug: Amlodipine10mg
PartB: Amlodipine, Amlodipine+Candesartan
Active Comparator group
Description:
Candesartan : multiple dose 32mg administered orally Amlodipine : multiple dose 10mg administered orally
Treatment:
Drug: Candesartan32mg
Drug: Amlodipine10mg

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems